EUVIMEDEUVIMED entdecken
Open Access

A novel anti-human CD25 mAb with preferential reactivity to activated T regulatory cells depletes them from the tumor microenvironment

Maja Buszko, Madalyn Jones, Sruthi Chempati, Lyra Morina, Kirstin Ward, Habtom Habte, Michael Dziegielewski, Ethan M Shevach

Oncotarget · 09.07.2025 · 16 (1) · 545-558

DOI: 10.18632/oncotarget.28752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, online erschienen am 09.07.2025. Verfasst von Maja Buszko und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Tumor Microenvironment, Interleukin-2 Receptor alpha Subunit, Antibodies, Monoclonal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryTumor MicroenvironmentInterleukin-2 Receptor alpha SubunitAntibodies, MonoclonalAnimalsHumansMiceLymphocyte ActivationFemaleCD8-Positive T-LymphocytesCell Line, TumorHybridomasXenograft Model Antitumor AssaysCell Proliferation

Stichwörter der Autor:innen

CD25GVHDTMETregmAb

Substanzen

Interleukin-2 Receptor alpha SubunitAntibodies, MonoclonalIL2RA protein, human

Autor:innen und Institutionen

  • Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.
  • Boehringer Ingelheim, Ridgefield, CT 06877, USA.

Zitieren

APA

Buszko, M., Jones, M., Chempati, S., Morina, L., Ward, K., Habte, H., Dziegielewski, M., & Shevach, E. M. (2025). A novel anti-human CD25 mAb with preferential reactivity to activated T regulatory cells depletes them from the tumor microenvironment. Oncotarget, 16(1), 545-558. https://doi.org/10.18632/oncotarget.28752

Vancouver

Buszko M, Jones M, Chempati S, Morina L, Ward K, Habte H, et al. A novel anti-human CD25 mAb with preferential reactivity to activated T regulatory cells depletes them from the tumor microenvironment. Oncotarget. 2025;16(1):545-558. doi:10.18632/oncotarget.28752

BibTeX
@article{Buszko2025,
  author = {Buszko, Maja and Jones, Madalyn and Chempati, Sruthi and Morina, Lyra and Ward, Kirstin and Habte, Habtom and Dziegielewski, Michael and Shevach, Ethan M},
  title = {A novel anti-human CD25 mAb with preferential reactivity to activated T regulatory cells depletes them from the tumor microenvironment},
  journal = {Oncotarget},
  year = {2025},
  volume = {16},
  number = {1},
  pages = {545--558},
  doi = {10.18632/oncotarget.28752}
}
Kostenlos starten →